David Opalka

Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay

David Opalka, Charles E. Lachman, Stefani A. MacMullen et al. · Clinical and Vaccine Immunology · 2003 · 278 citations · Full text

Viral Diagnostics, Immunology, Pathology +20

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

Joseph G. Joyce, Isaac J. Krauss, Hong Chang Song et al. · Proceedings of the National Academy of Sciences · 2008 · 128 citations · Full text

Immunology, Glycobiology, Immunotherapy +21

Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus Types

David Opalka, Katie Matys, Paul Bojczuk et al. · Clinical and Vaccine Immunology · 2010 · 69 citations · Full text

Viral Diagnostics, Immunology, Pathology +17

Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay

David Opalka, Antonello Pessi, Elisabetta Bianchi et al. · Journal of Immunological Methods · 2004 · 32 citations

Primary Immunodeficiency, Human Retrovirus, Immunology +7

HIV Type 1 Vaccines for Worldwide Use: Predicting In-Clade and Cross-Clade Breadth of Immune Responses

Adam C. Finnefrock, Xiaomei Liu, David Opalka et al. · AIDS Research and Human Retroviruses · 2007 · 12 citations

Immunology, Immunotherapy, Viral Evolution +19